AllianceBernstein
IBB icon

AllianceBernstein’s iShares Biotechnology ETF IBB Stock Holding History

AllianceBernstein’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-737,370
Closed -$82.4M – 3166
2019
Q1 		$82.4M Buy
737,370
+45,819
+7% +$5.03M 0.05% 360
2018
Q4 		$66.7M Sell
691,551
-45,628
-6% -$4.84M 0.05% 370
2018
Q3 		$89.9M Buy
737,179
+195,746
+36% +$23.1M 0.06% 340
2018
Q2 		$59.5M Sell
541,433
-204,857
-27% -$21.9M 0.04% 443
2018
Q1 		$79.7M Sell
746,290
-394,011
-35% -$43.7M 0.06% 349
2017
Q4 		$122M Sell
1,140,301
-764,873
-40% -$81.8M 0.09% 231
2017
Q3 		$212M Buy
1,905,174
+162,075
+9% +$17.3M 0.16% 136
2017
Q2 		$180M Buy
1,743,099
+298,773
+21% +$29.4M 0.14% 154
2017
Q1 		$141M Buy
1,444,326
+418,971
+41% +$40.1M 0.11% 185
2016
Q4 		$90.7M Buy
1,025,355
+121,917
+13% +$11.1M 0.08% 278
2016
Q3 		$87.2M Buy
+903,438
New +$85.9M 0.07% 291
2014
Q3 		– Sell
-2,604
Closed -$223K – 3432
2014
Q2 		$223K Buy
+2,604
New +$205K ﹤0.01% 2788
2013
Q4 		– Sell
-68,193
Closed -$4.76M – 3461
2013
Q3 		$4.76M Sell
68,193
-68,319
-50% -$4.48M ﹤0.01% 1096
2013
Q2 		$7.91M Buy
+136,512
New +$7.89M 0.01% 858

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AllianceBernstein's IBB Position: Q2 2019 in Review

AllianceBernstein sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 737,370 shares — an estimated $82.4M sold.

AllianceBernstein first reported a position in IBB in Q2 2013 and held it in 14 quarters. The position peaked at $212M in Q3 2017. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

  • AllianceBernstein reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
  • AllianceBernstein sold 737,370 iShares Biotechnology ETF shares in Q2 2019, an estimated $82.4M.
  • AllianceBernstein first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 14 quarters.
  • AllianceBernstein's iShares Biotechnology ETF position peaked at $212M in Q3 2017.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.